Cend Limited – Trademark Portfolio
Entity Type: 99
Cend Limited holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 29 (Meats & Processed Foods) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MYVITAMINS and FUEL YOUR AMBITION. The owner is based in Manchester.
Unit C
Ennis Close
Manchester M23 9LE , GB
Showing of trademarks Trademarks
Trademark Classifications
Cend Limited's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Cend Limited have?
Cend Limited has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Cend Limited file in?
Cend Limited files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 30 (Staple Foods), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Cend Limited's most well-known trademarks?
Cend Limited's registered trademark portfolio includes well-known marks such as MYVITAMINS and FUEL YOUR AMBITION. These are among 2 currently registered trademarks in the portfolio.
What is Cend Limited's trademark registration success rate?
Cend Limited has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.